HLN · Haleon plc · Proposed Sales
$8.66
+0.09 (+1.05%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$37.69B
Shares
4.40B
Volume · Oct 30
32.53M
Avg daily vol (3M)
15.88M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2023-12-29 | GlaxoSmithKline (US) Trust | Affiliate | 8,527,104 | 2023-12-27 | Citigroup Global Markets Inc |
| 2023-12-05 | GSK Master Grantor Trust | Affiliate | 404,599 | 2023-12-05 | BNY Mellon Capital Markets LLC |
| 2023-11-03 | GlaxoSmithKline Employee Trust | Affiliate | 173,611 | 2023-11-06 | Citigroup Global Markets Inc |
Showing 1–3 of 3 filings
Key facts
CIK
1900304
CUSIP
405552100
13F (30d)
247 filings
219 filers
Visit website
Investor relations